Ozempic pens in tray (Bloomberg/Getty)

A recent study has highlighted a concerning trend for those relying on weight loss medications: the return of lost weight and adverse health conditions within a mere two years. Published in the BMJ, the research reveals that individuals not only regain the shed kilos but also experience a resurgence of high cholesterol and blood pressure.

The study indicates that once treatment ends, weight begins creeping back at an average rate of 0.4 kilograms per month. Alongside this, health risks such as diabetes and heart disease markers are expected to revert to their initial levels in less than two years.

Interestingly, the analysis points out that weight regain after discontinuing such medications occurs almost four times faster than it does following lifestyle changes like diet and exercise. This rate holds true irrespective of the total weight lost during treatment.

Ozempic pens in tray (Bloomberg/Getty)
People who discontinue weight loss drugs return to their previous weight within less than two years, a new study has found.(Bloomberg/Getty)

The researchers noted, “This evidence suggests that, despite the initial success in achieving weight loss, these medications may not provide a sustainable solution for long-term weight management on their own.”

Although these drugs have become popular and significantly impacted obesity treatment, it is estimated that around 50% of users discontinue GLP-1 medications within just one year. This trend underscores the challenges in maintaining weight loss through pharmacological methods alone.

While the drugs are wildly popular and have transformed the treatment of obesity, it’s estimated that around half of people with obesity discontinue GLP-1 drugs within 12 months.

“The study findings cast doubt on the notion that GLP-1 receptor agonists are a perfect cure for obesity,” a US researcher said in a linked editorial.

“People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications.”

He said “healthy dietary and lifestyle practises” should remain the foundation of weight loss treatment and management, with the GLP-1 medications used as an aide.

“Such practises not only help prevent excess weight gain but can also lead to numerous health benefits that go beyond weight control,” he said.

You May Also Like

Sam Neill looked like he had all the time in the world as he slipped into the crowd at Sydney's ARIA Hall of Fame ceremony in June – his final public appearance before his sudden death at 78.

Friends Reflect on Sam Neill’s Final Days: Nobody Saw This Coming

The music was booming, the lights glowed softly, and Sam Neill appeared…
Three years before his passing, Sam Neill said he was unafraid of death but still had so much to live for

Sam Neill’s Candid Reflections on Mortality Resurface Amid Health Battle

Three years before his death, Sam Neill reflected candidly on mortality, saying…
Sam Neill, who died suddenly on Monday aged 78, boasted a vast property and winery empire, as well as a net worth estimated to be between $25 million and $28 million

Sam Neill Net Worth and Property Portfolio: Inside the Jurassic Park Star’s Fortune

Sam Neill, 78, remains one of New Zealand’s most recognisable screen figures,…
Sam Neill was suffering from pneumonia before his 'sudden' death on Monday at the age of 78

Sam Neill Death Rumors Debunked: Jurassic Park Star Is Alive Despite Viral Pneumonia Claims

Sam Neill had been battling pneumonia in the lead-up to his sudden…
Sam Neill was pictured for the final time four weeks ago in a sweet post shared on his Instagram profile, prior to his 'sudden and unexpected' death aged 78

Sam Neill Seen Smiling at ARIA Hall of Fame Awards Weeks Before Reported Death at 78

Sam Neill was seen in what became his final public Instagram post…